Membrane markers, target cell specificity, and sensitivity to biological response modifiers distinguish human natural cytotoxic from human natural killer cells.
Authors:
- M Rola-PleszczynskiMRM Rola-Pleszczynski
- H LieuHLH Lieu
- A K SullivanASA K Sullivan
- M GirardMGM Girard
Open Access
- 1 November 1985
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 76 (5) , 1927-1931
Abstract
In the present report, we provide evidence for the distinct existence of a human natural cytotoxic (HNC) cell. This HNC cell can be identified by the monoclonal antibody HNC-1A3 and by the absence of the T10 antigen, other antigenic markers being shared, at least in part, with natural killer (NK) cells, T cells, or monocytes. In addition, the HNC cell preferentially kills the MA-160 target, the herpes simplex virus-1-infected MA-160 cell line, and the two human tumor cell lines HEp-2 and HF-2. It has weak lytic activity against the NK-sensitive K562 cell line or its relatively NK-resistant clone I subline. The cytotoxic activity of the HNC cell is not augmented by interferon but is markedly enhanced by interleukin 2 and by a measles-virus-induced factor (MVF). Furthermore, it is not inhibited by cyclosporin A (CsA), in contrast to NK cell cytotoxicity against the K562 target cell line which is augmented by interferon, inhibited by CsA, and not affected by MVF. These data suggest that spontaneously cytotoxic cells may belong to more than one subset of human lymphocytes, and that HNC cells may be defined in man using membrane markers, target cell specificity, and sensitivity to biological response modifiers.Keywords
This publication has 19 references indexed in Scilit:
- Autologous herpes simplex virus-infected cells are lysed by human natural killer cells.The Journal of Immunology, 1983
- Leukotriene B4 augments human natural cytotoxic cell activityBiochemical and Biophysical Research Communications, 1983
- Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1.The Journal of Immunology, 1983
- Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.The Journal of Immunology, 1983
- The activity of natural cytotoxic cells is augmented by interleukin 2 and interleukin 3.Journal of Experimental Medicine, 1983
- Target cell specificity of human natural killer (NK) cellsCellular Immunology, 1983
- Studies of the cell lineage of the effector cells that spontaneously lyse HSV-1 infected fibroblasts (NK(HSV-1)).The Journal of Immunology, 1982
- Cyclosporin A permits the distinction between specific T and NK activity generated in A human MLCInternational Journal of Cancer, 1981
- Human large granular lymphocytes: spontaneous and interferon-boosted NK activity against adherent and nonadherent tumor cell lines.The Journal of Immunology, 1981
- A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1).The Journal of Immunology, 1981